SEC Company Response from WebMD Health Corp. (CIK 0001326583) — Sep 26, 2005
WebMD Health Corp. (CIK 0001326583)
Date: Sept. 26, 2005 · CIK: 0001326583 · Accession: 0000950157-05-000620
AI Filing Summary & Sentiment
File numbers found in text: 333-124832
Show Raw Text
CORRESP
1
filename1.htm
Registration Statement on Form S-1
September
26, 2005
VIA
EDGAR
U.S.
Securities and Exchange Commission
450
Fifth
Street, N.W.
Washington
D.C. 20549
Mail
Stop: 0409
Attention:
Ms. Elaine Wolff / Mr. Geoffrey Ossias
Re:
WebMD
Health Corp. (the “Company”)
Registration
Statement on Form S-1 (File No.
333-124832)
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, the undersigned hereby
join in the request of the Company that the effective date of the Registration
Statement be accelerated so that the Registration Statement may become effective
by 12:00 p.m. EST on the Wednesday of September 28, 2005 or as soon thereafter
as practicable.
The
comments of the Staff (the “Staff”) of the Securities and Exchange Commission
(the “Commission”) and the changes to the disclosure in the Company's filings in
response to the Staff’s comments on the above-referenced Registration Statement
do not foreclose the Commission from taking any action with respect to such
filings; and the Representatives may not assert Staff comments as a defense
in
any proceeding initiated by the Commission or any person under the federal
securities laws of the United States.
Sincerely,
MORGAN
STANLEY & CO. INCORPORATED
CITIGROUP
GLOBAL MARKETS INC.
As
Representatives
By: Morgan
Stanley & Co. Incorporated
/s/
John Tyree
Name:
John Tyree
Title:
Executive Director
September
26, 2005
VIA
EDGAR
U.S.
Securities and Exchange Commission
450
Fifth
Street, N.W.
Washington
D.C. 20549
Mail
Stop: 0409
Attention:
Ms. Elaine Wolff / Mr. Geoffrey Ossias
Re:
WebMD
Health Corp. (the “Company”)
Registration
Statement on Form S-1 (File No.
333-124832)
Ladies
and Gentlemen:
The
following information with respect to the distribution of the prospectus dated
September 19, 2005 is furnished pursuant to Rule 460 of the Rules and
Regulations of the Commission under the Securities Act of 1933, as amended,
in
connection with the request for acceleration of the effective date of the
aforementioned Registration Statement.
The
number of prospectuses dated September 19, 2005 as distributed between September
19, 2005 and September 23, 2005 is as follows:
No.
of Copies dated
September
19, 2005
To
Prospective Underwriters
21,067
to 4
To
Institutions
1,223
To
Individuals
3
To
Dealers
0
Total
22,293
We
were
advised on August 9, 2005 by the Corporate Finance Department of the
National Association of Securities Dealers, Inc. that it has reviewed the
above-captioned proposed offering and that it has determined to raise no
objections with respect to the fairness of the terms and arrangements of the
offering.
Sincerely,
MORGAN
STANLEY & CO. INCORPORATED
CITIGROUP
GLOBAL MARKETS INC.
As
Representatives
By: Morgan
Stanley & Co. Incorporated
/s/
John Tyree
Name:
John Tyree
Title:
Executive Director
September
26, 2005
VIA
EDGAR
U.S.
Securities and Exchange Commission
450
Fifth
Street, N.W.
Washington
D.C. 20549
Mail
Stop: 0409
Attention:
Ms. Elaine Wolff / Mr. Geoffrey Ossias
Re:
WebMD
Health Corp. (the “Company”)
Registration
Statement on Form S-1 (File No.
333-124832)
Ladies
and Gentlemen:
In
connection with the Preliminary Prospectus distribution for the above-mentioned
issue, the prospective underwriters have confirmed that they are complying
with
the 48-Hour requirement as promulgated by Rule 15c2-8 under the Securities
Exchange Act of 1934, as amended.
Sincerely,
MORGAN
STANLEY & CO. INCORPORATED
CITIGROUP
GLOBAL MARKETS INC.
As
Representatives
By: Morgan
Stanley & Co. Incorporated
/s/
John Tyree
Name:
John Tyree
Title:
Executive Director
3